These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 33341704)
1. Could trop-2 overexpression indicate tumor aggressiveness among prostatic adenocarcinomas? Akarken İ; Dere Y Ann Diagn Pathol; 2021 Feb; 50():151680. PubMed ID: 33341704 [TBL] [Abstract][Full Text] [Related]
2. TROP2 overexpression promotes proliferation and invasion of lung adenocarcinoma cells. Li Z; Jiang X; Zhang W Biochem Biophys Res Commun; 2016 Jan; 470(1):197-204. PubMed ID: 26773504 [TBL] [Abstract][Full Text] [Related]
3. TROP2 expression as prognostic marker for gastric carcinoma. Mühlmann G; Spizzo G; Gostner J; Zitt M; Maier H; Moser P; Gastl G; Zitt M; Müller HM; Margreiter R; Ofner D; Fong D J Clin Pathol; 2009 Feb; 62(2):152-8. PubMed ID: 18930986 [TBL] [Abstract][Full Text] [Related]
4. TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity. Fong D; Spizzo G; Gostner JM; Gastl G; Moser P; Krammel C; Gerhard S; Rasse M; Laimer K Mod Pathol; 2008 Feb; 21(2):186-91. PubMed ID: 18084248 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma. Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000 [TBL] [Abstract][Full Text] [Related]
6. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760 [TBL] [Abstract][Full Text] [Related]
7. High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Fong D; Moser P; Krammel C; Gostner JM; Margreiter R; Mitterer M; Gastl G; Spizzo G Br J Cancer; 2008 Oct; 99(8):1290-5. PubMed ID: 18813308 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway. Liu T; Liu Y; Bao X; Tian J; Liu Y; Yang X PLoS One; 2013; 8(9):e75864. PubMed ID: 24086649 [TBL] [Abstract][Full Text] [Related]
9. Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes. Inamura K; Yokouchi Y; Kobayashi M; Ninomiya H; Sakakibara R; Subat S; Nagano H; Nomura K; Okumura S; Shibutani T; Ishikawa Y Oncotarget; 2017 Apr; 8(17):28725-28735. PubMed ID: 28404926 [TBL] [Abstract][Full Text] [Related]
10. Role of tumor-associated macrophages in the Hexim1 and TGFβ/SMAD pathway, and their influence on progression of prostatic adenocarcinoma. Ok Atılgan A; Özdemir BH; Akçay EY; Ataol Demirkan Ö; Tekindal MA; Özkardeş H Pathol Res Pract; 2016 Feb; 212(2):83-92. PubMed ID: 26608417 [TBL] [Abstract][Full Text] [Related]
11. Association between focal adhesion kinase and matrix metalloproteinase-9 expression in prostate adenocarcinoma and their influence on the progression of prostatic adenocarcinoma. Ok Atılgan A; Özdemir BH; Yılmaz Akçay E; Tepeoğlu M; Börcek P; Dirim A Ann Diagn Pathol; 2020 Apr; 45():151480. PubMed ID: 32106037 [TBL] [Abstract][Full Text] [Related]
12. Clinical investigation of TROP-2 as an independent biomarker and potential therapeutic target in colon cancer. Zhao P; Yu HZ; Cai JH Mol Med Rep; 2015 Sep; 12(3):4364-4369. PubMed ID: 26059528 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of TROP2 expression in patients with gallbladder cancer. Chen MB; Wu HF; Zhan Y; Fu XL; Wang AK; Wang LS; Lei HM Tumour Biol; 2014 Nov; 35(11):11565-9. PubMed ID: 25135430 [TBL] [Abstract][Full Text] [Related]
14. Trophoblast Cell Surface Antigen 2 Expression in Human Tumors: A Tissue Microarray Study on 18,563 Tumors. Dum D; Taherpour N; Menz A; Höflmayer D; Völkel C; Hinsch A; Gorbokon N; Lennartz M; Hube-Magg C; Fraune C; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Marx AH; Simon R; Burandt E; Krech T; Luebke AM Pathobiology; 2022; 89(4):245-258. PubMed ID: 35477165 [TBL] [Abstract][Full Text] [Related]
15. Elevated expression of cancer-associated proliferating cell nuclear antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer. Wang X; Hickey RJ; Malkas LH; Koch MO; Li L; Zhang S; Sandusky GE; Grignon DJ; Eble JN; Cheng L Prostate; 2011 May; 71(7):748-54. PubMed ID: 21031434 [TBL] [Abstract][Full Text] [Related]
16. Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation. Zhang B; Gao S; Li R; Li Y; Cao R; Cheng J; Guo Y; Wang E; Huang Y; Zhang K BMC Cancer; 2020 Aug; 20(1):815. PubMed ID: 32854652 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of trophoblastic cell surface antigen 2 expression and pathologic parameters in patients with ampullary adenocarcinoma. Zhang Y; Wang H; Overman M; Katz MH; Wang H Hum Pathol; 2023 Sep; 139():117-125. PubMed ID: 37516386 [TBL] [Abstract][Full Text] [Related]
18. Significance of EpCAM and TROP2 expression in non-small cell lung cancer. Pak MG; Shin DH; Lee CH; Lee MK World J Surg Oncol; 2012 Apr; 10():53. PubMed ID: 22482828 [TBL] [Abstract][Full Text] [Related]
19. Trophoblast cell-surface antigen 2 (TROP2) expression in triple-negative breast cancer. Jeon Y; Jo U; Hong J; Gong G; Lee HJ BMC Cancer; 2022 Sep; 22(1):1014. PubMed ID: 36153494 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of TROP2 in human nasopharyngeal carcinoma. Guan GF; Zhang DJ; Wen LJ; Yu DJ; Zhao Y; Zhu L; Guo YY; Zheng Y Int J Clin Exp Pathol; 2015; 8(9):10995-1004. PubMed ID: 26617817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]